Eko Analysis Software vs Cardiomo
AI Verdict
Choose Eko Analysis Software if…
Choose Eko Analysis Software if you are a clinician seeking an FDA-cleared, AI-powered tool to enhance point-of-care cardiovascular disease detection during physical exams. It's ideal for quickly identifying heart murmurs and atrial fibrillation, recording and visualizing heart sounds and ECGs, and integrating these capabilities into existing clinical workflows, including telehealth.
View Eko Analysis Software →Choose Cardiomo if…
Choose Cardiomo if you require continuous, remote heart health monitoring for patients, particularly for long-term oversight of cardiovascular conditions and timely alerts to caregivers. This medical-grade wearable is well-suited for detecting arrhythmias and other cardiovascular events 24/7, offering peace of mind for both patients and their support network.
View Cardiomo →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Analysis Software | Cardiomo |
|---|---|---|
| Pricing | Freemium with subscription for full features | Contact for pricing |
| Deployment | Cloud-based | Cloud-based with wearable device and mobile app |
| FDA Status | 1 AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Analysis SoftwareEko Analysis Software integrates with familiar digital stethoscopes, offering a seamless workflow for clinicians during routine exams. Its mobile app and web dashboard provide clear visualizations and guided exam flows, making it intuitive for healthcare professionals. Cardiomo, while aiming for user-friendliness with its wearable patch, introduces a new device and continuous monitoring paradigm that might require a greater adjustment for both patients and caregivers.
Clinical Value
Eko Analysis SoftwareEko Analysis Software has multiple FDA clearances for detecting heart murmurs and atrial fibrillation, with published clinical validation studies demonstrating high sensitivity and specificity. Cardiomo also uses AI for disease detection and provides real-time alerts, but specific details on its clinical validation studies and FDA clearance status are less prominent in the provided information, although it mentions ISO 13485 certification and CE Mark Class IIa Medical Device status.
Pricing & Value
Eko Analysis SoftwareEko Analysis Software offers a freemium model with transparent subscription pricing for full AI features, allowing users to understand costs upfront. Cardiomo's current pricing is not publicly available, making it difficult to assess its value proposition without direct contact for a quote.
Enterprise Readiness
Eko Analysis SoftwareEko Analysis Software is positioned as an enterprise solution with its SENSORA platform, designed for health systems to scale AI-powered cardiac detection across specialties. It also offers features like EHR integration and a web dashboard for program management. Cardiomo focuses on remote monitoring and alerts for individuals and caregivers, with less emphasis on broad enterprise-level deployment features in the provided information.
Innovation
TieBoth tools demonstrate significant innovation in cardiovascular AI. Eko innovates by enhancing traditional auscultation with AI-powered digital stethoscopes for early detection at the point of care. Cardiomo innovates with its medical-grade wearable patch for continuous, remote monitoring and real-time alerts, representing a shift towards proactive, continuous health tracking.
Support & Docs
Eko Analysis SoftwareEko provides extensive support and documentation, including a comprehensive help center with FAQs, user manuals in multiple languages, and direct contact options for support. While Cardiomo offers a mobile application and aims to reduce the distance between patient and practitioner, specific details about its support resources and documentation are not as readily available.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Analysis Software | Cardiomo |
|---|---|---|
| Product Name | Eko Analysis Software | Cardiomo |
| Company | Eko Devices | Cardiomo, Inc. |
| Key AI Detection Capabilities | FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, Detection of normal sinus rhythm | AI-powered disease detection (arrhythmias, cardiovascular events) |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Wearables & Remote Monitoring (RPM) |
Videos
Demos, reviews, and walkthroughs featuring Eko Analysis Software and Cardiomo.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Analysis Software or Cardiomo
Backers
Who funded each tool's parent company.